Skip to content
Catalyst

methylene blueFinding

Methylene blue decreases all-cause mortality

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Nine out of the 11 included randomized trials reported mortality, which was significantly lower in the MB group (risk ratio, 0.60 [95% CI 0.43-0.84] p = 0.003), with findings confirmed in septic shock and cardiac surgery subgroups.”
Quoted verbatim from Methylene Blue Reduces Mortality in Critically Ill and Perioperative Patients: A Meta-Analysis of Randomized Trials.
This finding among the 158 findings on its endpoint

methylene blue

All-cause mortality

lowers

Effect as reported

CI 0.43 to 0.84

Who
critically ill and perioperative adult patients; mortality at longest follow-up, pooled across randomized trials
Dose studied
not reported

Very limited evidencePMID 37880041 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R2HAPWJFSAYS48W0HZY209